Active Surveillance IS Treatment for Early Prostate Cancer Prostate cancer (PCa) is the most prevalent cancer diagnosis annually among men. The majority of PCa diagnoses are indolent or early stage diagnoses.
Continue readingDoctors have found a new genetic signature useful for diagnosing bile duct cancer:
Continue reading“People don’t appreciate having stuff cut on their face a lot… They do it if there is a (skin cancer) there, but we want to take a proactive approach where we can give them something
Continue readingA new observational study of 2206 women who had lumpectomies for invasive breast cancers at four different institutions reveals that 509 of them had second operations in attempts to achieve wider clear
Continue readingThere is debate as to whether adjuvant chemotherapy along with resection is the proper course of treatment for biliary tract cancer.
Continue reading“A study published this week in the journal Carcinogenesis shows… grape seed extract (GSE) kills head and neck squamous cell carcinoma cells, while leaving healthy cells unharmed.” Regardless
Continue readingThough hysteroscopy plays an important role in both diagnosing and staging endometrial cancer, it may cause endometrial cancer cells to spread to the peritoneum, researchers say:
Continue reading“The root cause of many cases of myeloma is monoclonal gammopathy of undetermined significance (MGUS), a blood disorder where white blood cells produce too much M protein. While MGUS does not present
Continue reading“We are in the midst of a paradigm shift in screening (for prostate cancer) and risk assessment that no longer relies on a simple P.S.A. cutoff to determine who should be biopsied,” A longtime friend
Continue readingVitamin D may prevent the development of endometrial cancer, as it inhibited endometrial carcinogenesis in mice:
Continue readingExercise may be a critical component of endometrial cancer prevention, and walking for thirty minutes a day five days a week is enough to make a difference.
Continue reading“Breast cancer patients over the age of 60 with early-stage, hormone-responsive small tumors who forego adjuvant endocrine, also called hormonal therapy, are not at an increased risk of mortality
Continue reading